Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma

被引：0
|
作者：
P Kapoor
S Kumar
S J Mandrekar
K M Laumann
A Dispenzieri
M Q Lacy
D Dingli
M A Gertz
R A Kyle
P R Greipp
S V Rajkumar
T E Witzig
机构：
[1] Mayo Clinic,Division of Hematology
[2] Mayo Clinic,Division of Biomedical Statistics and Informatics
来源：
Leukemia | 2011年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1195 / 1197
页数：2
相关论文
共 50 条
  • [1] Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma
    Kapoor, P.
    Kumar, S.
    Mandrekar, S. J.
    Laumann, K. M.
    Dispenzieri, A.
    Lacy, M. Q.
    Dingli, D.
    Gertz, M. A.
    Kyle, R. A.
    Greipp, P. R.
    Rajkumar, S. V.
    Witzig, T. E.
    [J]. LEUKEMIA, 2011, 25 (07) : 1195 - 1197
  • [2] Thromboembolic events with lenalidomide-based therapy for multiple myeloma
    Menon, Smitha Patiyil
    Rajkumar, S. Vincent
    Lacy, Martha
    Falco, Patrizia
    Palumbo, Antonio
    [J]. CANCER, 2008, 112 (07) : 1522 - 1528
  • [3] Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
    Huang, Shang-Yi
    Lin, Chung-Wu
    Lin, Hsiu-Hsia
    Yao, Ming
    Tang, Jih-Luh
    Wu, Shang-Ju
    Chen, Yao-Chang
    Lu, Hsiao-Yun
    Hou, Hsin-An
    Chen, Chien-Yuan
    Chou, Wen-Chien
    Tsay, Woei
    Chou, Sheng-Je
    Tien, Hwei-Fang
    [J]. ANNALS OF HEMATOLOGY, 2014, 93 (08) : 1371 - 1380
  • [4] Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma
    T Vu
    W Gonsalves
    S Kumar
    A Dispenzieri
    M Q Lacy
    F Buadi
    M A Gertz
    S V Rajkumar
    [J]. Blood Cancer Journal, 2015, 5 : e363 - e363
  • [5] Characteristics of exceptional responders to lenalidomide-based therapy in multiple myeloma
    Vu, T.
    Gonsalves, W.
    Kumar, S.
    Dispenzieri, A.
    Lacy, M. Q.
    Buadi, F.
    Gertz, M. A.
    Rajkumar, S. V.
    [J]. BLOOD CANCER JOURNAL, 2015, 5 : e363 - e363
  • [6] Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
    Shang-Yi Huang
    Chung-Wu Lin
    Hsiu-Hsia Lin
    Ming Yao
    Jih-Luh Tang
    Shang-Ju Wu
    Yao-Chang Chen
    Hsiao-Yun Lu
    Hsin-An Hou
    Chien-Yuan Chen
    Wen-Chien Chou
    Woei Tsay
    Sheng-Je Chou
    Hwei-Fang Tien
    [J]. Annals of Hematology, 2014, 93 : 1371 - 1380
  • [7] Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
    A Palumbo
    S V Rajkumar
    M A Dimopoulos
    P G Richardson
    J San Miguel
    B Barlogie
    J Harousseau
    J A Zonder
    M Cavo
    M Zangari
    M Attal
    A Belch
    S Knop
    D Joshua
    O Sezer
    H Ludwig
    D Vesole
    J Bladé
    R Kyle
    J Westin
    D Weber
    S Bringhen
    R Niesvizky
    A Waage
    M von Lilienfeld-Toal
    S Lonial
    G J Morgan
    R Z Orlowski
    K Shimizu
    K C Anderson
    M Boccadoro
    B G Durie
    P Sonneveld
    M A Hussein
    [J]. Leukemia, 2008, 22 : 414 - 423
  • [8] Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
    Palumbo, A.
    Rajkumar, S. V.
    Dimopoulos, M. A.
    Richardson, P. G.
    Miguel, J. San
    Barlogie, B.
    Harousseau, J.
    Zonder, J. A.
    Cavo, M.
    Zangari, M.
    Attal, M.
    Belch, A.
    Knop, S.
    Joshua, D.
    Sezer, O.
    Ludwig, H.
    Vesole, D.
    Blade, J.
    Kyle, R.
    Westin, J.
    Weber, D.
    Bringhen, S.
    Niesvizky, R.
    Waage, A.
    von Lilienfeld-Toal, M.
    Lonial, S.
    Morgan, G. J.
    Orlowski, R. Z.
    Shimizu, K.
    Anderson, K. C.
    Boccadoro, M.
    Durie, B. G.
    Sonneveld, P.
    Hussein, M. A.
    [J]. LEUKEMIA, 2008, 22 (02) : 414 - 423
  • [9] Similar efficacy of thalidomide- and bortezomib-based regimens for first relapse of multiple myeloma
    Marta Krejci
    Evzen Gregora
    Jan Straub
    Jiri Minarik
    Vlastimil Scudla
    Zdenek Adam
    Andrea Krivanova
    Ludek Pour
    Lenka Zahradova
    Tomas Buchler
    Jiri Mayer
    Roman Hajek
    [J]. Annals of Hematology, 2011, 90 : 1441 - 1447
  • [10] Treatment of Multiple Myeloma: Thalidomide-, Bortezomib-, and Lenalidomide-Induced Peripheral Neuropathy
    Koeppen, Susanne
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (09) : 506 - 513
12345